TG Therapeutics TGTX Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| License | $9.36M-38.7% | $15.28M-89.2% | $141.66M+93,095% | $152K0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does TG Therapeutics break its business down?
- TG Therapeutics (TGTX) reports revenue by product across 2 parts — License and License Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does TG Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in TG Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
